ERG–TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin
Modern Pathology2011Vol. 24(8), pp. 1120–1127
Citations Over TimeTop 10% of 2011 papers
Sean R. Williamson, Shaobo Zhang, Jorge L. Yao, Jiaoti Huang, Antonio López-Beltrán, Steven S. Shen, Adeboye O. Osunkoya, Gregory T. MacLennan, Rodolfo Montironi, Liang Cheng
Related Papers
- → Delineation of TMPRSS2-ERG Splice Variants in Prostate Cancer(2008)96 cited
- → Association of ERG and TMPRSS2‐ERG with grade, stage, and prognosis of prostate cancer is dependent on their expression levels(2015)65 cited
- → Combined analysis of TMPRSS2–ERG and TERT for improved prognosis of biochemical recurrence in prostate cancer(2012)23 cited
- Structure and expression of TMPRSS2-ERG splice variants in prostate cancer(2008)
- → Figure S2 from Loss of FOXO1 Cooperates with TMPRSS2–ERG Overexpression to Promote Prostate Tumorigenesis and Cell Invasion(2023)